Skip to main content
European Commission logo print header

Development of an immunotherapy for breast cancer based on dendritic cells by developing and comparing different types of tumor specific immunogens

Obiettivo

This project aims for the development of an effective immunotherapy for breast cancer, based on dendrite cell vaccines. This includes the generation of dendrite cells, the production of breast cancer related immunises, the development and improvement of new strategies for enhanced antigen presentation the in vitro evaluation of immune response using patients T-cells and mouse models and the transfer of the most successful approach to GMP as well the design of a clinical trial. The project requires collaboration between medical oncologists and scientists with expertise in cancer immunology, dendrite cells therapy, biotechnology, basic molecular biology and glycobiology. Cancer vaccines based on dendrite cells are the focus of attention worldwide and the leading company in Europe; IDM is a participant in this project.

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

FORSCHUNGSZENTRUM JUELICH GMBH
Contributo UE
Nessun dato
Indirizzo
Leo-Brand-Strasse
52425 JUELICH
Germania

Mostra sulla mappa

Collegamenti
Costo totale
Nessun dato

Partecipanti (7)